NanoLogix Launches New Family of “Quick-Tests” Designed to Identify Bacteria 3 to 4 Times Faster Than Traditional Technology
October 13 2010 - 8:45AM
Business Wire
NanoLogix, Inc. (PINK SHEETS: NNLX) announces its new Quick-Test
product line for detection and identification of aerobic live-cell
bacteria. With the NanoLogix Quick-Tests, the research community
will be able to obtain high-sensitivity analysis results in reduced
time with lower costs than traditional technologies. The new
NanoLogix Quick Test product line complements the Company’s
existing BNP and BNF membrane and filtration technologies with a
projected market of medical laboratories, food and beverage
producers, pharmaceutical, university and other institutional
users.
NanoLogix Quick-Test kit (Photo: Business
Wire)
The NanoLogix Quick-Tests detect and identify a multitude of
live-cell bacteria, such as E.coli, Salmonella, and Listeria, with
the additional capability of rapid identification of yeasts. These
results can be obtained in as little as a quarter of the time of
conventional methods, in concentrations potentially as small as a
single cell.
Dr. Sergey Gazenko, developer of BNC, BNP, and BNF technologies
stated, “We’ve taken our current, peer-reviewed technology and
developed the Quick-Test technology to assist in reducing the time
required in sample analysis and subsequent diagnosis.”
“With infectious diseases being the second leading cause of
death worldwide, the demand for fast, inexpensive and simple
testing methods that do not require specialized equipment or
complex training is growing. To assist in satisfying that demand,
NanoLogix's Quick-Tests were developed to provide the ability to
obtain rapid analysis results without large capital expenditures
and increased burdens on existing staff,” said Bret Barnhizer,
NanoLogix CEO.
Each Quick-Test kit is designed to provide results for fifty
individual tests of the targeted bacteria and each test kit is
identified by the name of that specific bacteria, e.g., E.coli
Quick-Test, Salmonella Quick-Test, etc. NanoLogix currently has
Quick Tests available for E.coli, Salmonella, and Listeria with
additional bacteria Quick-Tests available upon request.
For more information please visit www.nanologix.com.
Update On NanoLogix and US EPA CRADA
The Cooperative Research and Development Agreement recently
signed between NanoLogix and the United States Environmental
Protection Agency with the goal of improving comprehensive water
quality testing runs through 2012. For more details pertaining to
the NanoLogix CRADA with the EPA, please visit, http://www.epa.gov/microbes/mceardnewsarchive.html.
About NanoLogix, Inc.
NanoLogix is a biotechnology company focused primarily on rapid
diagnostics. Its products offer accelerated detection and
identification of microorganisms. In addition to medical and
homeland security applications, NanoLogix technology is applicable
in pharmaceutical, industrial, veterinary and environmental
testing.
Patents granted to NanoLogix can be used in the areas of applied
microbiology, soil microbiology and bioremediation, microbial
physiology, molecular biology, pharmacology, pharmaco-kinetics, and
antibiotic sensitivity
For more information visit www.nanologix.com.
This press release contains statements, which may constitute
"forward- looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those
statements include statements regarding the intent, belief or
current expectations of NanoLogix, Inc., and members of its
management as well as the assumptions on which such statements are
based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may
differ materially from those contemplated by such forward-looking
statements. The Company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6465626&lang=en
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Jun 2024 to Jul 2024
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Jul 2023 to Jul 2024